302 related articles for article (PubMed ID: 25559827)
1. Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis.
Skorić B; Čikeš M; Ljubas Maček J; Baričević Ž; Škorak I; Gašparović H; Biočina B; Miličić D
Croat Med J; 2014 Dec; 55(6):562-76. PubMed ID: 25559827
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
Cheng R; Vanichsarn C; Patel JK; Currier J; Chang DH; Kittleson MM; Makkar R; Kobashigawa JA; Azarbal B
Catheter Cardiovasc Interv; 2017 Jul; 90(1):48-55. PubMed ID: 27862865
[TBL] [Abstract][Full Text] [Related]
3. Cardiac allograft vasculopathy: current concepts.
Ventura HO; Smart FW; Stapleton DD; Toups T; Price HL
J La State Med Soc; 1993 May; 145(5):195-8, 200-2. PubMed ID: 8393471
[TBL] [Abstract][Full Text] [Related]
4. Drug eluting versus bare metal stents in cardiac allograft vasculopathy: a systematic review of literature.
Dasari TW; Hennebry TA; Hanna EB; Saucedo JF
Catheter Cardiovasc Interv; 2011 Jun; 77(7):962-9. PubMed ID: 21413135
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous coronary interventions and bypass surgery in patients with cardiac allograft vasculopathy: a single-center experience.
Prada-Delgado O; Estévez-Loureiro R; López-Sainz A; Gargallo-Fernández P; Paniagua-Martín MJ; Marzoa-Rivas R; Barge-Caballero E; Cuenca-Castillo JJ; Castro-Beiras A; Crespo-Leiro MG
Transplant Proc; 2012 Nov; 44(9):2657-9. PubMed ID: 23146485
[TBL] [Abstract][Full Text] [Related]
6. Cardiac allograft vasculopathy.
Lee MS; Finch W; Weisz G; Kirtane AJ
Rev Cardiovasc Med; 2011; 12(3):143-52. PubMed ID: 22080925
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. One center's experience.
Aranda JM; Pauly DF; Kerensky RA; Cleeton TS; Walker TC; Schofield RS; Leach D; Lin L; Monroe V; Calderon RE; Hill JA
J Heart Lung Transplant; 2002 Aug; 21(8):860-6. PubMed ID: 12163085
[TBL] [Abstract][Full Text] [Related]
8. New developments in the diagnosis and management of cardiac allograft vasculopathy.
Mehra MR; Ventura HO; Smart FW; Stapleton DD; Collins TJ; Ramee SR; Murgo JP; White CJ
Tex Heart Inst J; 1995; 22(2):138-44. PubMed ID: 7647597
[TBL] [Abstract][Full Text] [Related]
9. Cardiac allograft vasculopathy.
Behrendt D; Ganz P; Fang JC
Curr Opin Cardiol; 2000 Nov; 15(6):422-9. PubMed ID: 11198625
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation.
Lee MS; Yang T; Fearon WF; Ho M; Tarantini G; Xhaxho J; Gerosa G; Weston M; Ehdaie A; Rabbani L; Kirtane AJ
Am J Cardiol; 2010 Oct; 106(8):1086-9. PubMed ID: 20920643
[TBL] [Abstract][Full Text] [Related]
11. Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy.
Lee MS; Kobashigawa J; Tobis J
JACC Cardiovasc Interv; 2008 Dec; 1(6):710-5. PubMed ID: 19463388
[TBL] [Abstract][Full Text] [Related]
12. "Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy".
Pighi M; Gratta A; Marin F; Bellamoli M; Lunardi M; Fezzi S; Zivelonghi C; Pesarini G; Tomai F; Ribichini F
Transplant Rev (Orlando); 2020 Oct; 34(4):100569. PubMed ID: 32739137
[TBL] [Abstract][Full Text] [Related]
13. Cardiac allograft vasculopathy: A review.
Lee MS; Tadwalkar RV; Fearon WF; Kirtane AJ; Patel AJ; Patel CB; Ali Z; Rao SV
Catheter Cardiovasc Interv; 2018 Dec; 92(7):E527-E536. PubMed ID: 30265435
[TBL] [Abstract][Full Text] [Related]
14. Robotic Coronary Artery Bypass Grafting for Transplant Vasculopathy.
Torregrossa G; Bravo M; Mancini D; Puskas J
Ann Thorac Surg; 2019 Aug; 108(2):e77-e79. PubMed ID: 30710522
[TBL] [Abstract][Full Text] [Related]
15. Cardiac allograft vasculopathy.
Rhodes LR
Crit Care Nurs Q; 2004; 27(1):10-6. PubMed ID: 14974521
[TBL] [Abstract][Full Text] [Related]
16. Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study.
Jeewa A; Chin C; Pahl E; Atz AM; Carboni MP; Pruitt E; Naftel DC; Rodriguez R; Dipchand AI;
J Heart Lung Transplant; 2015 Sep; 34(9):1163-8. PubMed ID: 25578627
[TBL] [Abstract][Full Text] [Related]
17. Cardiac allograft vasculopathy--coronary interventions and surgical options.
Pethig K; Heublein B; Haverich A
Z Kardiol; 2000; 89 Suppl 9():IX/66-9. PubMed ID: 11151798
[TBL] [Abstract][Full Text] [Related]
18. Comparison of drug-eluting versus bare metal stents in cardiac allograft vasculopathy.
Tremmel JA; Ng MK; Ikeno F; Hunt SA; Lee DP; Yeung AC; Fearon WF
Am J Cardiol; 2011 Sep; 108(5):665-8. PubMed ID: 21684511
[TBL] [Abstract][Full Text] [Related]
19. Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation.
Lopez-Fernandez S; Manito-Lorite N; Gómez-Hospital JA; Roca J; Fontanillas C; Melgares-Moreno R; Azpitarte-Almagro J; Cequier-Fillat A
Clin Transplant; 2014 Dec; 28(12):1393-401. PubMed ID: 25284267
[TBL] [Abstract][Full Text] [Related]
20. Surgical revascularization for cardiac allograft vasculopathy: Is it still an option?
Bhama JK; Nguyen DQ; Scolieri S; Teuteberg JJ; Toyoda Y; Kormos RL; McCurry KR; McNamara D; Bermudez CA
J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1488-92. PubMed ID: 19464469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
